Published in Am J Obstet Gynecol on August 01, 1973
Log normal distribution of ovarian and placental steroid values in early human pregnancy. Arch Gynecol (1978) 0.79
Diagnosis of allergy by an in-vitro test for allergen antibodies. Lancet (1967) 6.12
Deliveries and children born after in-vitro fertilisation in Sweden 1982-95: a retrospective cohort study. Lancet (1999) 5.63
A new class of immunoglobulin in human serum. Immunology (1968) 4.19
Clinical significance of specific IgE to common allergens. I. Relationship of specific IgE against Dermatophagoides spp. and grass pollen to skin and nasal tests and history. Clin Allergy (1971) 2.31
Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer (1999) 2.31
Assisted reproductive technology in Europe, 2008: results generated from European registers by ESHRE. Hum Reprod (2012) 2.28
Induction of sex hormone binding globulin by phenytoin. Br Med J (1977) 2.13
Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE. Hum Reprod (2010) 2.04
Risk of stillbirth and infant deaths after assisted reproductive technology: a Nordic study from the CoNARTaS group. Hum Reprod (2014) 2.01
Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis. Hum Reprod Update (2012) 1.98
Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHRE. Hum Reprod (2008) 1.78
Progesterone levels in peripheral plasma during the luteal phase of the normal human menstrual cycle measured by a rapid competitive protein binding technique. Acta Endocrinol (Copenh) (1969) 1.75
Radioimmunoassays employing immunosorbents. Acta Endocrinol Suppl (Copenh) (1969) 1.74
Hypocalcemia and parathyroid hormone secretion in critically ill patients. Crit Care Med (2000) 1.73
Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis. Effect of glucocorticoids. J Rheumatol (1996) 1.73
Radioimmunoassay of 2 -microglobulin in human biological fluids. Scand J Clin Lab Invest (1971) 1.71
Reaginic antibody (IgE), skin, and provocation tests to Dermatophagoides culinae and house dust in respiratory allergy. Lancet (1969) 1.59
Depression of the progesterone levels in women treated with synthetic gestagens after ovulation. Acta Endocrinol (Copenh) (1971) 1.57
International Committee for Monitoring Assisted Reproductive Technologies (ICMART) world report: assisted reproductive technology 2004. Hum Reprod (2013) 1.57
Serum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency department. Eur J Clin Invest (1997) 1.54
High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab (1998) 1.51
Assisted reproductive technology in Europe, 2001. Results generated from European registers by ESHRE. Hum Reprod (2005) 1.49
Marked erythropoietin increase before fall in Hb after treatment with cytostatic drugs suggests mechanism other than anaemia for stimulation. Br J Haematol (1989) 1.47
The effect of various dosages of lynestrenol on the plasma levels of oestrogens and progesterone during the menstrual cycle in the rhesus monkey. Contraception (1976) 1.47
Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab (1992) 1.47
Marked gender differences in ambulatory morning growth hormone values in young adults. Clin Chem (1998) 1.46
Growth hormone treatment affects brain neurotransmitters and thyroxine [see comment]. Clin Endocrinol (Oxf) (1996) 1.46
Disturbance of basal and stimulated serum levels of intact parathyroid hormone in primary hyperparathyroidism. Surgery (1991) 1.45
Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival. Ann Surg (1987) 1.41
The LH-releasing hormone test in 31 women with secondary amenorrhoea. J Obstet Gynaecol Br Commonw (1972) 1.40
Multifetal pregnancy reduction in Sweden. Utilization rate and pregnancy outcome (1986-1992) Acta Obstet Gynecol Scand (1994) 1.40
[Do maternal benefits mean worse maternal health services?]. Lakartidningen (1993) 1.39
Plasma levels of progesterone after vaginal, rectal, or intramuscular administration of progesterone. Am J Obstet Gynecol (1971) 1.38
Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE. Hum Reprod (2006) 1.38
FSH, LH, TeBG-capacity, estrogen and progesterone in women with premenstrual tension during the luteal phase. J Steroid Biochem (1976) 1.35
Cerebrospinal fluid ferritin in patients with cerebral infarction or bleeding. Acta Neurol Scand (1980) 1.34
Assisted reproductive technology in Europe, 2000. Results generated from European registers by ESHRE. Hum Reprod (2004) 1.33
Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors. Cancer (1990) 1.28
Assisted reproductive technology in Europe, 2003. Results generated from European registers by ESHRE. Hum Reprod (2007) 1.28
Detection of circulating IgG aggregates and immune complexes using 125I protein A from Staphylococcus aureus. Ann Rheum Dis (1976) 1.25
Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab (1995) 1.23
Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance--a prospective randomized double-blind study. Acta Med Scand (1987) 1.23
Assisted reproductive technology in Europe, 2007: results generated from European registers by ESHRE. Hum Reprod (2012) 1.23
Immunological aspects of respiratory allergy in budgerigar (Melopsittacus undulatus) fanciers. Clin Allergy (1971) 1.22
Hospital care utilization of infants born after IVF. Hum Reprod (2002) 1.21
Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study. Am J Hypertens (1989) 1.21
Variation in LH and FSH response to LH-releasing hormone during the menstrual cycle. J Obstet Gynaecol Br Commonw (1972) 1.21
Gonadal function and glycoprotein hormones in the carbohydrate-deficient glycoprotein (CDG) syndrome. Acta Paediatr (1995) 1.20
Radioimmunoassay of oestrone and oestradiol in human and bovine peripheral plasma. Acta Endocrinol (Copenh) (1972) 1.12
Inhibitory effects on gonadotrophin secretion and gonadal function in men during chronic treatment with a potent stimulatory luteinizing hormone-releasing hormone analogue. Acta Endocrinol (Copenh) (1979) 1.12
Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumors. Br Med J (1978) 1.11
Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results. Cancer Treat Rep (1986) 1.10
Impaired glucose handling in active rheumatoid arthritis: relationship to the secretion of insulin and counter-regulatory hormones. Metabolism (1987) 1.10
Relationship between the plasma levels of luteinizing hormone and progesterone during the normal menstrual cycle. J Clin Endocrinol Metab (1967) 1.09
Neonatal outcome in pregnancies from ovarian stimulation. Obstet Gynecol (2002) 1.09
Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab (1991) 1.08
Menstrual function and serum prolactin levels after long-term bromocriptine treatment of hyperprolactinaemic amenorrhoea. Clin Endocrinol (Oxf) (1982) 1.06
In vitro fertilisation in Sweden: obstetric characteristics, maternal morbidity and mortality. BJOG (2005) 1.06
Correlates of pregnancy oestrogen, progesterone and sex hormone-binding globulin in the USA and China. Eur J Cancer Prev (2002) 1.05
Effects of thyrotrophin-releasing hormone on plasma levels of TSH, FSH, LH and GH in anorexia nervosa. Eur J Clin Invest (1972) 1.04
Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent. Acta Endocrinol (Copenh) (1982) 1.04
Detection of penicillin allergy of the immediate type by radioimmunoassay of reagins (IgE) to penicilloyl conjugates. Clin Allergy (1971) 1.04
Parathyroid hormone and ionized calcium levels are related to the severity of illness and survival in critically ill patients. Eur J Clin Invest (1998) 1.03
Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombinant human erythropoietin. Ann Rheum Dis (1992) 1.03
Cerebrospinal fluid calcium, parathyroid hormone, and monoamine and purine metabolites and the blood-brain barrier function in primary hyperparathyroidism. Psychoneuroendocrinology (1991) 1.02
Serum prolactin in patients with hypothalamus and pituitary disorders. J Neurosurg (1981) 1.02
Thyrotropin-releasing hormone testing during antithyroid drug treatment of Graves' disease as an indicator of remission. J Clin Endocrinol Metab (1985) 1.02
Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy. Eur J Clin Invest (1983) 1.02
Practice and patterns of estrogen treatment in climacteric women in a Swedish population. A descriptive epidemiological study. Part I. Acta Obstet Gynecol Scand (1983) 1.02
A standardized meal stimulation test of the endocrine pancreas for early detection of pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: five years experience. J Clin Endocrinol Metab (1987) 1.01
Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia. Cancer (1976) 1.00
Progesterone level and response to oxytocin at term. Lancet (1968) 1.00
Thyroid disease and function in breast cancer patients and non-hospitalized controls evaluated by determination of TSH, T3, rT3 and T4 levels in serum. Acta Chir Scand (1978) 0.99
Allergens and antigens of Dermatophagoides farinae. Clin Exp Immunol (1970) 0.98
Inhibition of ovulation in women by intranasal treatment with a luteinizing hormone-releasing hormone agonist. Contraception (1979) 0.97
Plasma levels of nonconjugated oestrone, oestradiol-17beta and oestriol during uncomplicated pregnancy. Acta Obstet Gynecol Scand Suppl (1974) 0.97
Iodine status, thyroid function and pregnancy: study of Swedish and Sudanese women. Eur J Clin Nutr (1998) 0.96
Testosterone as a biological marker in psychopathy and alcoholism. Psychiatry Res (1998) 0.96
Effects of continuous daily administration of 0.03 mg of d-norgestrel on the plasma levels of progesterone and the urinary excretion of oestrogens. Acta Endocrinol (Copenh) (1971) 0.96
Intranasal gonadotropin-releasing hormone agonist as a contraceptive agent. Lancet (1979) 0.96
Neuroendocrine pancreatic tumours: clinical presentation, biochemical and histopathological findings in 84 patients. J Intern Med (1990) 0.96
Induction of male puberty by long-term pulsatile subcutaneous LH-RH therapy. Ups J Med Sci (1984) 0.95
Periovulatory progesterone concentration in the peripheral plasma of the rhesus monkey with a methodologic note on the detection of ovulation. Endocrinology (1968) 0.95
The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Clin Endocrinol (Oxf) (1994) 0.95
Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls. Ups J Med Sci (1979) 0.95
Serum ferritin during infection. A longitudinal study. Scand J Haematol (1978) 0.95
Clinical patterns and results of radioallergosorbent test (RAST) and skin tests in penicillin allergy. Br J Dermatol (1976) 0.95
A radiosorbent technique for the assay of serum vitamin B12. Scand J Clin Lab Invest (1971) 0.94
Metabolic clearance of human chorionic gonadotrophin administered to non pregnant women. Acta Endocrinol (Copenh) (1968) 0.93
Impaired glucose handling in active rheumatoid arthritis: effects of corticosteroids and antirheumatic treatment. Metabolism (1987) 0.93
Glucose tolerance and insulin response during daily continuous low-dose oral contraceptive treatment. Acta Endocrinol (Copenh) (1969) 0.93
Oral contraceptives after intestinal bypass operations. JAMA (1976) 0.93
Low serum dehydroepiandrosterone sulfate in women with primary Sjögren's syndrome as an isolated sign of impaired HPA axis function. J Rheumatol (2001) 0.93
Luteinizing hormone (LH) and progesterone in plasma and LH and oestrogens in urine during 42 normal menstrual cycles. Acta Endocrinol (Copenh) (1971) 0.93
Plasma levels of progesterone in pregnancy measured by a rapid competitive protein binding technique. Acta Endocrinol (Copenh) (1969) 0.92
Serum prolactin and gonadotrophin levels before and after luteinizing hormone-releasing hormone in the investigation of amenorrhoea. Br J Obstet Gynaecol (1978) 0.92
Determination of fibrinogen and fibrinolysis products in human plasma by an immunochemical method. Scand J Clin Lab Invest (1965) 0.92
Serum erythropoietin in the diagnosis of polycythaemia and after phlebotomy treatment. Br J Haematol (1992) 0.92